Investor information
Cash distributions
| Year | Cash distribution per share (in CHF) | Ex-date | Payment date |
|---|---|---|---|
| 2018 | 5.50 1.50 |
27.06.2018 19.09.2018 |
29.06.2018 21.09.2018 |
| 2017 | 5.80 | 28.06.2017 | 30.06.2017 |
| 2016 | 5.50 | 28.06.2016 | 30.06.2016 |
| 2015 | 5.50 | 01.07.2015 | 06.07.2015 |
| 2014 | 3.00 | 24.06.2014 | 27.06.2014 |
| 2013 | 1.50 | 04.09.2013 | 09.09.2013 |
Significant shareholders
Based on the notifications received by the Company, the following shareholders reported equity holdings in HBM Healthcare Investments Ltd of three percent or more as at 31 March 2018:
| Shareholding | Shareholder |
|---|---|
| 15 - 20% | Nogra Pharma Invest S.à.r.l., Luxemburg |
See here for details about significant shareholders in HBM Healthcare Investments Ltd. (SIX Swiss Exchange).
Fees
Management fees (paid quarterly):
0.75% of company assets plus
0.75% of the company's market capitalisation
Performance fee (paid annually):
15% on increase in value above the high water mark. High water mark (per share for all outstanding shares) for financial year 2018/2019: NAV of CHF 161.87.
Presentations
HBM Healthcare Investments Company Presentation
HBM Healthcare Investments Factsheet
HBM Healthcare Investments Shareholders' Meeting 2018 Presentation
Analyst reports
Management transactions
See here for details about Management transactions in HBM Healthcare Investments' shares (SIX Swiss Exchange).
Articles of association
Articles of Association of HBM Healthcare Investments Ltd.
Share buy-back programme 2016
The maximum permissible daily repurchase volume in accordance with Art. 123 para. 1 lit. (c) FinfraV amounts to 2389 shares.
HBM Healthcare Investments launches a new share buy-back programme
Rückkauf eigener Aktien zum Zweck der Kapitalherabsetzung (German)
Rachat d’actions propres dans le but d’une réduction de capital (French)